12-6462882-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014231.5(VAMP1):​c.*1588T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.709 in 1,595,188 control chromosomes in the GnomAD database, including 402,871 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.70 ( 37884 hom., cov: 33)
Exomes 𝑓: 0.71 ( 364987 hom. )

Consequence

VAMP1
NM_014231.5 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.0740

Publications

30 publications found
Variant links:
Genes affected
VAMP1 (HGNC:12642): (vesicle associated membrane protein 1) Synapotobrevins, syntaxins, and the synaptosomal-associated protein SNAP25 are the main components of a protein complex involved in the docking and/or fusion of synaptic vesicles with the presynaptic membrane. The protein encoded by this gene is a member of the vesicle-associated membrane protein (VAMP)/synaptobrevin family. Mutations in this gene are associated with autosomal dominant spastic ataxia 1. Multiple alternative splice variants have been described, but the full-length nature of some variants has not been defined. [provided by RefSeq, Jul 2014]
TAPBPL (HGNC:30683): (TAP binding protein like) Tapasin, or TAPBP (MIM 601962), is a member of the variable-constant Ig superfamily that links major histocompatibility complex (MHC) class I molecules to the transporter associated with antigen processing (TAP; see MIM 170260) in the endoplasmic reticulum (ER). The TAPBP gene is located near the MHC complex on chromosome 6p21.3. TAPBPL is a member of the Ig superfamily that is localized on chromosome 12p13.3, a region somewhat paralogous to the MHC.[supplied by OMIM, Mar 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 12-6462882-A-G is Benign according to our data. Variant chr12-6462882-A-G is described in ClinVar as [Benign]. Clinvar id is 1234868.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.768 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VAMP1NM_014231.5 linkc.*1588T>C 3_prime_UTR_variant Exon 5 of 5 ENST00000396308.4 NP_055046.1 P23763-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VAMP1ENST00000396308.4 linkc.*1588T>C 3_prime_UTR_variant Exon 5 of 5 2 NM_014231.5 ENSP00000379602.3 P23763-1

Frequencies

GnomAD3 genomes
AF:
0.704
AC:
107072
AN:
152040
Hom.:
37845
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.719
Gnomad AMI
AF:
0.647
Gnomad AMR
AF:
0.652
Gnomad ASJ
AF:
0.573
Gnomad EAS
AF:
0.777
Gnomad SAS
AF:
0.790
Gnomad FIN
AF:
0.707
Gnomad MID
AF:
0.604
Gnomad NFE
AF:
0.704
Gnomad OTH
AF:
0.656
GnomAD2 exomes
AF:
0.692
AC:
151463
AN:
219004
AF XY:
0.697
show subpopulations
Gnomad AFR exome
AF:
0.710
Gnomad AMR exome
AF:
0.587
Gnomad ASJ exome
AF:
0.576
Gnomad EAS exome
AF:
0.769
Gnomad FIN exome
AF:
0.708
Gnomad NFE exome
AF:
0.692
Gnomad OTH exome
AF:
0.668
GnomAD4 exome
AF:
0.710
AC:
1024573
AN:
1443030
Hom.:
364987
Cov.:
81
AF XY:
0.711
AC XY:
509193
AN XY:
715800
show subpopulations
African (AFR)
AF:
0.715
AC:
23705
AN:
33152
American (AMR)
AF:
0.593
AC:
24698
AN:
41680
Ashkenazi Jewish (ASJ)
AF:
0.571
AC:
14720
AN:
25762
East Asian (EAS)
AF:
0.784
AC:
30527
AN:
38938
South Asian (SAS)
AF:
0.786
AC:
65303
AN:
83100
European-Finnish (FIN)
AF:
0.707
AC:
36992
AN:
52350
Middle Eastern (MID)
AF:
0.584
AC:
3350
AN:
5736
European-Non Finnish (NFE)
AF:
0.711
AC:
783725
AN:
1102562
Other (OTH)
AF:
0.695
AC:
41553
AN:
59750
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
18662
37325
55987
74650
93312
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19794
39588
59382
79176
98970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.704
AC:
107161
AN:
152158
Hom.:
37884
Cov.:
33
AF XY:
0.704
AC XY:
52387
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.720
AC:
29861
AN:
41500
American (AMR)
AF:
0.652
AC:
9968
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.573
AC:
1991
AN:
3472
East Asian (EAS)
AF:
0.777
AC:
4011
AN:
5164
South Asian (SAS)
AF:
0.788
AC:
3808
AN:
4830
European-Finnish (FIN)
AF:
0.707
AC:
7481
AN:
10588
Middle Eastern (MID)
AF:
0.619
AC:
182
AN:
294
European-Non Finnish (NFE)
AF:
0.704
AC:
47878
AN:
67992
Other (OTH)
AF:
0.660
AC:
1395
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1687
3375
5062
6750
8437
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
840
1680
2520
3360
4200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.686
Hom.:
48032
Bravo
AF:
0.694
Asia WGS
AF:
0.761
AC:
2644
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 15, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spastic ataxia 1 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Myasthenic syndrome, congenital, 25, presynaptic Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
8.3
DANN
Benign
0.72
PhyloP100
0.074
Mutation Taster
=47/53
disease causing

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1045452; hg19: chr12-6572048; COSMIC: COSV56947017; COSMIC: COSV56947017; API